Amgen stock price forecast technical analysis projects Amgen stock

Technical analysis projects Amgen stock price forecast near $297 by next quarter, supported by ascending moving average trends and positive MACD crossover in recent trading sessions. The true power of the LEAPS strategy becomes apparent in the most optimistic scenarios. If Novo Nordisk rebounds to its all-time high of $140, the LEAPS investor's returns would be significantly higher in percentage terms than those of the common stock investor due to the embedded leverage. Furthermore, the capital saved by choosing the LEAPS option can be invested elsewhere (e.g. short-term fixed income securities that currently yields around 4% per year), generating additional returns. This dual-strategy approach allows for a high-conviction sentiment on a potential recovery while also creating a separate, lower-risk income stream, offsetting some of the primary risk of the options trade. 5 Hot Stocks to Buy Now: October's Top Picks With Major Upside Market sentiment around Amgen remains positive, as its stable revenue growth and defensive healthcare sector position support a projected stock price forecast between $290 and $308 for the coming months. RSI levels point to moderate bullishness.